Counterfeit anti-infective drugs.

The production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to spurious reporting of resistance and toxicity and loss of confidence in health-care systems. Counterfeit drugs pa...

Full description

Bibliographic Details
Main Authors: Newton, P, Green, MD, Fernández, F, Day, N, White, N
Format: Journal article
Language:English
Published: 2006
_version_ 1797063874964357120
author Newton, P
Green, MD
Fernández, F
Day, N
White, N
author_facet Newton, P
Green, MD
Fernández, F
Day, N
White, N
author_sort Newton, P
collection OXFORD
description The production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to spurious reporting of resistance and toxicity and loss of confidence in health-care systems. Counterfeit drugs particularly affect the most disadvantaged people in poor countries. Although advances in forensic chemical analysis and simple field tests will enhance drug quality monitoring, improved access to inexpensive genuine medicines, support of drug regulatory authorities, more open reporting, vigorous law enforcement, and more international cooperation with determined political leadership will be essential to counter this threat.
first_indexed 2024-03-06T21:06:12Z
format Journal article
id oxford-uuid:3c8c12d2-fa6e-4658-aedf-8e106bc02273
institution University of Oxford
language English
last_indexed 2024-03-06T21:06:12Z
publishDate 2006
record_format dspace
spelling oxford-uuid:3c8c12d2-fa6e-4658-aedf-8e106bc022732022-03-26T14:14:16ZCounterfeit anti-infective drugs.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3c8c12d2-fa6e-4658-aedf-8e106bc02273EnglishSymplectic Elements at Oxford2006Newton, PGreen, MDFernández, FDay, NWhite, NThe production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to spurious reporting of resistance and toxicity and loss of confidence in health-care systems. Counterfeit drugs particularly affect the most disadvantaged people in poor countries. Although advances in forensic chemical analysis and simple field tests will enhance drug quality monitoring, improved access to inexpensive genuine medicines, support of drug regulatory authorities, more open reporting, vigorous law enforcement, and more international cooperation with determined political leadership will be essential to counter this threat.
spellingShingle Newton, P
Green, MD
Fernández, F
Day, N
White, N
Counterfeit anti-infective drugs.
title Counterfeit anti-infective drugs.
title_full Counterfeit anti-infective drugs.
title_fullStr Counterfeit anti-infective drugs.
title_full_unstemmed Counterfeit anti-infective drugs.
title_short Counterfeit anti-infective drugs.
title_sort counterfeit anti infective drugs
work_keys_str_mv AT newtonp counterfeitantiinfectivedrugs
AT greenmd counterfeitantiinfectivedrugs
AT fernandezf counterfeitantiinfectivedrugs
AT dayn counterfeitantiinfectivedrugs
AT whiten counterfeitantiinfectivedrugs